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 2 
Abstract 23 
Macrophage phagocytosis of pathogens and tumour cells is an important early event in 24 
protection against infectious disease and cancer. As tumour necrosis factor α (TNF) is an 25 
important cytokine in macrophage activation, we investigated the involvement of TNF in 26 
macrophage phagocytosis of tumour cells. We used Devil Facial Tumour Disease (DFTD) 27 
cancer cells as the target tumour cells. The Tasmanian devil (Sarcophilus harrisii) population 28 
is threatened by the transmissible DFTD. Using DFTD cells provided the opportunity to 29 
determine if these cells can be phagocytosed and investigate requirement for TNF. As effector 30 
cells, bone marrow derived macrophages (BMDMs), generated from C57BL/6 wild type 31 
(B6.WT) and C57BL/6 TNF-/- (B6.TNF-/-) mice were used. Phagocytosis of DFTD cells was 32 
investigated by confocal microscopy and flow cytometry. DFTD cells were consistently 33 
phagocytosed by B6.WT and B6.TNF-/- BMDMs with similar efficiency in vitro. Consequently 34 
the DFTD cells are not resistant to phagocytosis. Following activation by exposure to IFNγ and 35 
LPS or LPS alone, B6.TNF-/- BMDMs had higher phagocytic efficiency and lower nitric oxide 36 
(NO) production compared to wild-type controls. In addition, NO seems to be unlikely to be 37 
the involved in phagocytosis efficiency in IFNγ and LPS activated B6.TNF-/- macrophages and 38 
consequences thereof. Our results indicate that TNF is not required for IFNγ and LPS or LPS 39 
alone activation of macrophage phagocytosis. TNF may negatively regulate macrophage 40 
phagocytosis of tumour cells. 41 
  42 
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Introduction 43 
Tumour necrosis factor α (TNF) is a member of the tumour necrosis factor family with two 44 
cognate receptors, TNF receptor 1 (TNFR1) and TNFR2 (Sedgwick et al., 2000). Under steady-45 
state conditions TNF is synthesised at low levels predominantely by T cells and macrophages, 46 
but following challenge macrophages increase the production of TNF dramatically (Mannel et 47 
al., 1980).  48 
Macrophages are a heterogeneous population of innate immune cells with important roles in 49 
tissue regeneration and immune defence (Hu et al., 2017). One of their evolutionary oldest 50 
effector functions is phagocytosis, the engulfment of pathogens or cells debris, or more general, 51 
particles followed by an uptake of the engulfed material in specialised vesicles termed phago-52 
lysosomes (Aderem and Underhill, 1999). This mechanism was originally described over 100  53 
years ago (Tauber, 2003) and involves receptor recognition, cytoskeleton rearrangement and 54 
phagosome maturation (Taylor et al., 2005). During the process of phagocytosis pathogens are 55 
endocytosed and become engulfed as membrane coated phagosomes. The phagosomes then 56 
fuse with lysosome to form an acidic environment to degrade the pathogens (Underhill and 57 
Ozinsky, 2002). Actin polymerization is required for pathogen uptake and reactive oxygen and 58 
nitrogen species contribute to the degradation of the pathogen (Aderem and Underhill, 1999).  59 
In response to environmental stimuli, macrophages differentiate into classically activated, 60 
proinflammatory (M1) macrophages or alternatively activated, anti-inflammatory (M2) 61 
macrophages. M1 macrophages require exposure to the pro-inflammatory cytokines interferon 62 
gamma (IFNγ) either alone or in combination with TNF or a Toll like receptor ligand such as 63 
LPS. M2 macrophages require exposure to IL-4 and/or IL-13 (Murray et al., 2014). The 64 
differentiation to either M1 or M2 macrophages is not only driven by cytokines but also 65 
negatively regulated by TNF. The presence of TNF is necessary for macrophages to 66 
differentiate to the M1 type. In absence of TNF a significant proportion of macrophages co-67 
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expresses the M2-marker Arginase-1 (Arg1) interfering with the production of NO (Kratochvill 68 
et al., 2015; Schleicher et al., 2016).  69 
Interestingly, and in agreement with their different functions, M1 and M2 macrophages display 70 
different levels of phagocytosis (Gordon and Martinez, 2010; Varin et al., 2010). IFNγ 71 
activation of M1 macrophages enhances phagocytosis of apoptotic cells (Fernandez-72 
Boyanapalli et al., 2010). In contrast, IL-4 induced M2 macrophages exhibit impaired bacterial 73 
phagocytosis due to reduced phagosome formation (Varin et al., 2010). Specifically, TNF 74 
inhibits macrophage phagocytosis of apoptotic cells in a time and dose dependent manner 75 
(Borges et al., 2009). TNF deficient macrophages have a reduced ability to endocytose 76 
nontypeable Haemophilus influenza (Leichtle et al., 2010). However, TNF appears to enhance 77 
IFNγ primed macrophage phagocytosis of apoptotic cells in a NO dependent manner  78 
(Fernandez-Boyanapalli et al., 2010). Therefore, the effects of TNF in macrophage 79 
phagocytosis under different activation states of macrophages are unclear. Consequently, we 80 
investigated role of TNF in macrophage phagocytosis of tumour cells under different activation 81 
conditions.  82 
The tumour cells used in this study were Devil Facial Tumour Disease (DFTD) cells. The first 83 
case of DFTD was recorded in 1996 and is primarily responsible for the catastrophic decline 84 
of the Tasmanian devil (Sarcophilus harrisii) population (Jones et al., 2008). In 2016 a second 85 
and independent DFTD was discovered and has been called DFT2 to distinguish it from the 86 
first DFTD, now identified as DFT1 (Pye et al., 2016b). DFTD is a transmissible cancer 87 
transmitted as an allograft by biting and is characterized by tumours located on face and neck 88 
of diseased devils (Jones et al., 2008). Functional and histological analyses performed to date 89 
indicate that the devil has a competent adaptive immune system (Kreiss et al., 2009). Since it 90 
is pracytically and ethically problematic to harvest tissues from S. harrisii many aspects of the 91 
innate immune system have not yet been explored and mouse models need to be established. 92 
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For example, it is unknown if DFTD cells can be phagocytosed by mouse macrophages and if 93 
these cells after considering limitations can be used as model. 94 
Therefore, we firstly determined if DFTD cells could be phagocytosed then examined the 95 
activation status of macrophages and the effect of TNF on their ability to phagocytose DFTD 96 
cells. We used bone marrow derived macrophages (BMDMs) isolated from wild type and 97 
B6.TNF-/- mice and found that TNF inhibits macrophage phagocytosis efficiency following 98 
activation by IFNγ/LPS and LPS.  99 
  100 
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Materials and Methods 101 
Animals   102 
The gene-targeted C57BL/6 (B6.TNF-/-) mouse strains deficient for TNF were generated on a 103 
genetically pure C57BL/6 (B6.WT) background as described (Körner et al., 1997). The 104 
screening procedure followed the protocols described previously (Körner et al., 1997). All 105 
animals were housed in pathogen-free conditions. Mice aged 8-16 weeks were used in all 106 
experiments. The experiments were approved by the Animal Ethics Committee of University 107 
of Tasmania (UTAS) under the ethics number A13934.  108 
Cell culture 109 
BMDM from B6.WT and B6.TNF-/- mice were generated from pelvic and femoral bones as 110 
described (Schleicher and Bogdan, 2009). BMDM were cultured in RPMI 1640 medium 111 
(Gibco, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS, Gibco, USA), 112 
10% L929-conditioned medium (containing M-CSF), 5% horse serum (Gibco, USA), 1% 113 
penicillin and streptomycin (Gibco, USA), 1% nonessential amino acids (Gibco, USA) and 2-114 
mercaptotoethanol (Gibco, USA). After culture for 7 days, BMDM were untreated or treated 115 
with the following substances: 20 ng/ml IFNγ (Peprotech, USA), 100 ng/ml LPS (Sigma, USA) 116 
or a combination of IFNγ and LPS for 24 hours or 5 ng/ml IL-4 (Peprotech, USA) for 48 hours. 117 
The purity of macrophages obtained was always at least 90% by using CD11b (PE-cy7, 118 
eBioscience) and F4/80 (PerCP Cy5.5, Biolegend) in flow cytometry.  119 
The Devil Facial Tumour Disease cell line, C5065, was established from primary tumour 120 
samples (Pearse et al., 2012). Cells were grown in RPMI-1640 medium (Gibco, USA) 121 
supplemented with 10% FBS (Bovogen Biological, Australia) and 5mM L-glutamine (Sigma, 122 
USA). DFTD cells were maintained in a humidified 5% CO2 incubator at 35 °C. Phagocytosis 123 
assays required co-culturing of mouse macrophages with DFTD cells were maintained at 37 °C. 124 
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Flow cytometry phagocytosis assay and calculations 126 
BMDM (effector cells) were labelled with CellTrace™ Violet (CTV, Invitrogen, USA), DFTD 127 
cells (target cells) were labelled with 5(6)-Carboxyfluorescein diacetate N-succinimidyl ester 128 
(CFSE, Invitrogen, USA) according to manufacturer’s instruction. BMDMs were resuspended 129 
in cell culture medium at 106/ml. Serial dilution of 100 µl BMDMs were performed to obtain 130 
effector to target ratios of 10:1, 5:1 with 104 target cells. The phagocytosis assays were 131 
performed in duplicate or triplicate and incubated for 4 hours and 24 hours at 37 °C and for 4 132 
hours at 4 °C for the negative control. The plates were analysed on a BD Canto II flow 133 
cytometer and data calculations were performed with Flowjo V10.1 software (Tree star, USA), 134 
and Graphpad Prism 5 for graphic display. To calculate percentage of DFTD cells 135 
phagocytosed, three gates were identified. R1, total CFSE+ tumour cells = total tumour cells. 136 
R2, CFSE+/CTV+ dual labelled cells = tumour cells phagocytized by macrophages. R3, 137 
CFSE+/CTV- cells = free tumour cells. The formula used for calculating phagocytosis was as 138 
follows: percentage of phagocytosis= R2/R1 x 100. For the 24 hours incubation (to avoid the 139 
complication of cell division of DFTD cells), the absolute numbers of DFTD cells were 140 
calculated by including all events (i.e. cells) or enumerating with a known number of cell count 141 
beads (eBioscience, USA) added to enable absolute numbers to be determined by ratio. For the 142 
bead count method, 5,000 beads were added to wells before the analysis by flow cytometry. 143 
The number of cells and beads were recorded and the number of DFTD cells not phagocytosed 144 
were calculated according to the ratio of analysed beads to 5,000. The number of DFTD cells 145 
remaining = (5000/number of beads collected) x R3 cells. Spontaneous DFTD cell death during 146 
short term assays was negligible. 147 
 148 
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Cell staining and confocal microscopy for evidence of phagocytosis 149 
CTV labelled BMDMs were grown in 24 well plates on 0.2% gelatine (BD Bioscience, USA) 150 
coated 12 mm coverslips. CFSE labelled DFTD cells were added when the coverslip was 151 
almost confluent with BMDMs. After 4 and 24 hours incubation, cells were gently washed 152 
with PBS. Cells were permeabilized with 0.25% Triton X-100 (Sigma, USA)  for 20 min and 153 
blocked with a 1% BSA (Sigma, USA) in PBS solution for 20 min. Antibody staining was 154 
conducted for 30 min with a rabbit anti-mouse-LAMP1 antibody (BD Bioscience, USA). The 155 
goat anti rabbit Alexa Fluor 594 (BD Pharmingen, USA) secondary antibody was applied for 156 
30 min. The cells were washed three times in PBS and mounted using Dako mounting medium 157 
(DakoCytomation, Australia). Confocal microscopy was performed using spinning disk and z-158 
stacks were taken in slices of 1 µm.  159 
Griess assay 160 
The content of NO in the cell culture media was determined by Griess assay as described 161 
previously (Wilhelm et al., 2001). 50 µl cell culture medium was mixed with equal volumes of 162 
Griess reagents (1% sulphanilamide in 2.5% H3PO4, Sigma, USA), then 50 µl Griess reagent 163 
(0.1% napthylenediamide dihydrochloride, Sigma, USA) was added and incubated at room 164 
temperature for 10 min. The absorbance at 540 nm was measured by a microplate reader (Bio-165 
Rad, USA) and compared to a standard nitrite curve using sodium nitrite (Sigma, USA).  166 
Statistical analysis  167 
Flow cytometry was conducted at least three times in duplicate or triplicate wells. Statistical 168 
significance was determined by Student’s unpaired t-test. P values of less than 0.05 were 169 
considered statistically significant.  170 
 171 
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Results 173 
DFTD cells can be phagocytosed by macrophages from B6.WT and B6.TNF-/-mice.  174 
To determine if DFTD cells could be phagocytosed, BMDMs from B6.WT and B6.TNF-/- mice 175 
(CTV labelled; blue) were co-incubated with DFTD C5065 cells (CFSE-labelled; green). After 176 
4 hours and 24 hours culture, phagocytosis was analysed by confocal microscopy (Figure 1). 177 
Green DFTD cells could be identified within the blue macrophages from both B6.WT and 178 
B6.TNF-/- mice. When z-stacks were analysed the green fragments were identified inside the 179 
macrophages, suggesting the tumour cells had been engulfed (Fig 1). The degradation of 180 
phagocytosed cellular material involves the process of phagosome maturation through 181 
homotypic and heterotypic fusion of early endosomes, late endosomes and lysosomes (Zhou 182 
and Yu, 2008). The presence of lysosomal-associated membrane protein 1 (LAMP1) was used 183 
to discriminate a late phase of phagocytosis, after phagosomes/lysosome fusion (Tjelle et al., 184 
2000). As BMDMs from B6.WT and B6.TNF-/- mice can phagocytose DFTD cells, it suggests 185 
that TNF is not essential for phagocytosis and that DFTD cells are not resistant to phagocytosis.  186 
 187 
TNF deficiency results in enhanced phagocytic capacity in IFNγ/LPS treated 188 
macrophages. 189 
Confocal microscopy showed that DFTD cells are phagocytosed by BMDMs from B6.WT and 190 
B6.TNF-/- mice, but flow cytometry was used to determine phagocytic efficiency. BMDMs 191 
were labelled with CTV and DFTD cells were labelled with CFSE, then incubated at ratios of 192 
E:T (10:1 and 5:1) at 37 ºC or 4 ºC for 4 hours. The phagocytosed DFTD cells were recognized 193 
as CFSE and CTV double positive cells. In the absence of stimulation (control) the phagocytic 194 
efficiencies of BMDMs from B6.WT and B6.TNF-/- mice were similar at both 10:1 (Fig 2A, 195 
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Suppl. Figure 1) and 5:1 (Fig 2B, Suppl. Figure 1) ratios. It suggests that TNF is not required 196 
for macrophage phagocytosis of DFTD cells under steady-state conditions.  197 
In order to determine TNF involvement in phagocytosis following macrophage activation, 198 
BMDMs were stimulated with IFNγ and LPS, IFNγ alone, LPS alone or IL-4 alone. Following 199 
IFNγ/LPS activation, macrophages from B6.TNF-/- mice displayed enhanced phagocytosis 200 
efficiency at both 10:1 (Fig 2A, Suppl. Figure 1) and 5:1 (Fig 2B, Suppl. Figure 1) ratios, 201 
compared with macrophages from B6.WT mice. However, BMDM macrophages from 202 
B6.TNF-/- mice stimulated with IFNγ or IL-4 did not show a significant difference in phagocytic 203 
efficiency, compared with BMDM from B6.WT mice (Fig 2A, 2B, Suppl. Figure 1). Compared 204 
to untreated BMDMs, LPS treatment enhanced the phagocytic efficiency of BMDMs from 205 
wild-type and B6.TNF-/- mice (Fig 2A, 2B, Suppl. Figure 1). But no significant difference was 206 
shown between BMDMs from wild-type and B6.TNF-/- mice groups following LPS activation. 207 
To confirm that the CFSE and CTV double positive cells represented phagocytosis rather than 208 
cell binding, DFTD cells and macrophages were co-incubated at 4 ºC for 4 hours (Fig 2C, 2D, 209 
Suppl. Figure 1). The proportion of double positive cells was substantially reduced providing 210 
support for phagocytosis at 37 ºC rather than just binding to the cell surface.                                                                               211 
 212 
IFNγ/LPS, LPS activated BMDM from B6.TNF-/- mice phagocytose DFTD cells more 213 
effectively than BMDM from B6.WT mice following 24 hours incubation. 214 
The phagocytosis and subsequent disappearance of DFTD cells was analysed with flow 215 
cytometry after 24 hours incubation by enumerating the viable DFTD cells remaining. The 216 
absolute number of free DFTD cells was calculated using cell count beads. IFNγ/LPS and LPS 217 
alone activated BMDMs from B6.TNF-/- mice cultured with DFTD cells for 24 hours resulted 218 
in fewer DFTD cells remaining compared to BMDMs from B6.WT mice at 10:1 and 5:1 ratios 219 
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(Fig 3A, 3B, Suppl. Figure 2). However, IFNγ or IL-4 activated BMDMs from B6.TNF-/- mice 220 
had similar number of DFTD cells with wild-type controls at 10:1 and 5:1 ratios (Fig 3A, 3B, 221 
Suppl. Figure 2). These results indicated that LPS and potentially IFNγ/LPS activated 222 
macrophages from B6.TNF-/- mice phagocytosed more DFTD cells than macrophages from the 223 
B6.WT mice. Thus, although phagocytosis by activated BMDMs was observed in the presence 224 
of TNF, the absence of TNF appeared to increase the phagocytic activity. 225 
 226 
The production of NO is diminished from IFNγ/LPS or LPS activated B6.TNF-/- 227 
macrophages after incubation with DFTD cells for 24 hours. 228 
The effector molecule NO is an essential macrophage product and is cytotoxic to tumour cells 229 
(MacMicking et al., 1997). As TNF regulates the production of NO in macrophages (Ding et 230 
al., 1988), we determined whether NO is related to TNF regulation of macrophage 231 
phagocytosis of DFTD cells. IFNγ/LPS, IFNγ or LPS treated macrophages from B6.WT, 232 
B6.TNF-/- mice were co-incubated with DFTD cells for 24 hours and the NO contents in the 233 
cell culture supernatant were measured. As shown in Fig 4, untreated macrophages from both 234 
mouse genotypes did not produce any detectable NO. In response to IFNγ/LPS activation, 235 
BMDMs from B6.TNF-/- mice produced less NO than wild type controls. This was evident at 236 
10:1 (Fig 4A) and 5:1 (Fig 4B) ratios. Similarly, less NO was released from LPS activated 237 
BMDMs from B6.TNF-/- mice than wild type controls (Fig 4A, 4B). The IFNγ treatment did 238 
not alter NO production of B6.WT, B6.TNF-/- macrophages after incubation with DFTD cells 239 
for 24 hours (Fig 4A, 4B). The production of NO might associate with the alteration of 240 
phagocytosis in IFNγ/LPS and LPS alone treated B6.TNF-/- macrophages. 241 
 242 
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TNF-associated alteration of macrophage phagocytosis during treatment with IFNγ/LPS 243 
seems independent of NO production.   244 
To determine the association of NO with increased phagocytic activity in IFNγ/LPS treated 245 
B6.TNF-/- macrophages. NO production was blocked by the inhibitor of NO synthesis, L-N6- 246 
(1-Iminoethyl) lysine dihydrochlorideinducible (L-NIL). After the incubation with IFNγ/LPS 247 
or IFNγ/LPS and L-NIL for 24 hours, BMDMs from B6.WT and B6.TNF-/- mice were co-248 
incubated with DFTD cells for 24 hours. The number of DFTD cells was measured by flow 249 
cytometry and cell counting beads. As shown in Fig 5, L-NIL did not alter phagocytosis 250 
following stimulation with IFNγ/LPS of macrophages from B6.WT or B6. TNF-/- mice. In 251 
addition, compared to IFNγ/LPS treatment, L-NIL treatment did not alter the phagocytic ability 252 
of macrophages from B6.WT or B6.TNF-/- mice (Fig 5). Thus, it suggests that NO was 253 
unrelated to the altered phagocytic ability of IFNγ/LPS treated macrophages from B6.TNF-/- 254 
mice. 255 
  256 
 14 
Discussion 257 
Our study shows that DFTD cells are phagocytosed effectively by murine BMDMs and that 258 
TNF modulates this ability. While we acknowledge the limitations imposed on far reaching 259 
conclusions by the experimental combination of mouse macrophage and devil tumor cells the 260 
main consequences of our findings are that an avoidance of phagocytosis by DFTD cells is 261 
unlikely to contribute to immune escape and that TNF is not necessary for phagocytosis, but 262 
negatively regulates phagocytosis by activated macrophages. Antibody-dependent 263 
phagocytosis was not explored in this project because cross-species effects are unknown. 264 
The absence of MHC-I expression on DFT1 cells prevents the activation of CD8+ T cells and 265 
thus interferes with the adaptive cellular immune response (Siddle et al., 2013). Nevertheless, 266 
devils immunised with DFTD antigens (Kreiss et al., 2015; Tovar et al., 2017) and some 267 
DFTD-inoculated devils (Pye et al., 2016a) can produce DFTD-specific antibodies which is in 268 
line with antibody mediated opsonisation of DFT1 cells and subsequent phagocytosis of tumor 269 
cells by macrophages. However, tumour cells can avoid phagocytosis by expressing inhibitory 270 
molecules such as CD47 which is part of the immune checkpoint inhibitory pathway (Alvey 271 
and Discher, 2017), and CD47 has been identified in transcriptome analysis from devil 272 
mononuclear cells (Flies et al., 2017). Hence, there is the potential for DFT1 cells to express 273 
this molecule. In the absence of monoclonal antibodies to identify inhibitory molecules and in 274 
particular CD47, we conducted phagocytosis experiments of DFT1 cells by flow cytometry 275 
and confocal microscopy using bone marrow-derived mouse macrophages in a proof of 276 
principle approach. We could show that DFT1 cells can be phagocytosed supporting the notion 277 
that antibody-opsonised DFT1 cells could also be sensitive to phagocytosis in vivo in the 278 
Tasmanian devil after immunization (Kreiss et al., 2015; Pye et al., 2016a; Tovar et al., 2017).  279 
After determining that mouse macrophages effectively phagocytose DFT1 tumour cells we 280 
then investigated whether TNF was required. In the absence of stimulation, the presence of 281 
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TNF made no difference to the phagocytic efficiency. But following activation with IFNγ/LPS 282 
or LPS (but not IFNγ), the presence of TNF reduced phagocytic activity. Although TNF is 283 
regarded as a master regulator of inflammatory cytokine production (Parameswaran and Patial, 284 
2010) there are reports that TNF can inhibit macrophage phagocytic activity. Exogenous TNF 285 
has been shown to reduce the macrophage capacity to ingest apoptotic cells (McPhillips et al., 286 
2007). This inhibition appears specific for apoptotic cells as it is not seen with beads or 287 
antibody-opsonized cells (McPhillips et al., 2007). The authors propose that within the 288 
inflammatory environment, the reduced phagocytic ability may ‘contribute to the local 289 
intensity of the inflammatory response’. Macrophages stimulated with LPS produce TNF and 290 
this would inhibit macrophage phagocytosis of apoptotic cells in an autocrine manner (Feng et 291 
al., 2011). TNF is also produced by IFNγ/LPS activated macrophages (Cohen et al., 2015; Patel 292 
et al., 2012). IFNγ on its own is unable to activate macrophages to produce TNF, but can do so 293 
in the presence of LPS (Gifford and Lohmann-Matthes, 1987). This observation is 294 
controversial as some studies have shown that IFNγ primed macrophages (Fernandez-295 
Boyanapalli et al., 2010; Vila-del Sol et al., 2008) can produce TNF. Furthermore, IFNγ 296 
appears to restore an impaired ability of macrophages to phagocytose apoptotic cells in a nitric 297 
oxide-dependent manner that requires TNF production (Fernandez-Boyanapalli et al., 2010; 298 
Vila-del Sol et al., 2008). This might be due to the macrophages coming from different sources 299 
and at different stages of maturation. A further caveat is the potential presence of traces of 300 
contaminating TLR ligands. Already minute amounts can interfere with the activation of 301 
macrophages. Finally, while TNF has no effect on phagocytosis by immature macrophages, it 302 
can reduce phagocytosis by mature macrophages (McPhillips et al., 2007). 303 
Phagocytosis of pathogens by macrophages requires NO and TNF dependent NO production 304 
is required for the enhanced phagocytosis of apoptotic cells by IFNγ activated macrophages 305 
(Fernandez-Boyanapalli et al., 2010). However, NO can impair phagocytosis of fluorescent 306 
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particles by affecting cytoskeletal assembly and pseudopod formation (Jun et al., 1996). TNF 307 
is definitely involved in NO production as it induces iNOS expression via the NF- κB signaling 308 
pathway (Ding et al., 1988; Patel et al., 2012). Furthermore, the expression of iNOS 309 
downstream of IFNγ/LPS activation of macrophages requires TNF (Chan and Riches, 2001). 310 
TNF dependent NO production is required for the enhanced phagocytosis of apoptotic cells by 311 
IFNγ activated macrophages (Fernandez-Boyanapalli et al., 2010). We blocked production of 312 
NO by using L-NIL, but inhibition of NO production did not alter phagocytosis efficiency in 313 
IFNγ/LPS treated macrophages. It suggests that NO is independent of TNF presence in 314 
IFNγ/LPS treated macrophages. Moreover, actin polymerization is an essential event in the 315 
process of macrophage phagocytosis. It has been suggested that exogenous TNF decreases 316 
actin reorganization in J774 macrophages (Peppelenbosch et al., 1999). The involvement of 317 
actin and TNF inhibition of phagocytosis activity in IFNγ/LPS activated macrophages needs 318 
to be further investigated. Finally, recent observations point to a new role for TNF in the 319 
maintenance of a M1 phenotype in macrophages (Kratochvill et al., 2015; Schleicher et al., 320 
2016). Since we used TNF-negative macrophages in our experiments we cannot exclude the 321 
possibility that a part of the cell population has differentiated to M2 macrophages with 322 
consequences for their ability to produce pro-inflammatory mediators and phagocytose tumor 323 
cells. This aspect has to be explored in further detailed studies.  324 
 325 
 326 
 327 
 328 
  329 
 17 
Acknowledgements  330 
We thank Terry Pinfold for assistance using flow cytometry, and Peta Lawrie and Paul Scanon 331 
for animal husbandry. We also thank Yilan Zhen for advice on the performance of confocal 332 
microscopy. XL was supported by a AMU/UTAS postgraduate scholarship and research funds 333 
were provided by grants from the Australian Research Council (DP130100715, LP130100218) 334 
and the Dr Eric Guiler Tasmanian devil research grants administered through the University of 335 
Tasmania Foundation. Part of the data in this manuscript have been presented as poster at the 336 
ICI Melbourne in 2016 and have been published in the conference proceedings: Li X., Lyons 337 
A. B., Körner H. & G. Woods. (2016) Murine macrophage phagocytosis of devil facial tumour 338 
disease cells. European Journal of Immunology 46, 439 (supplement) Meeting Abstract 422. 339 
(published abstract). 340 
  341 
 342 
Conflict of interest 343 
The authors state that they had no conflict of interest. 344 
  345 
 18 
Figures legends 346 
Figure 1. Confocal microscope analysis of macrophage phagocytosing DFTD cells. Co-347 
incubate CTV labelled BMDMs with CFSE labelled DFTD cells for 4 hours and 24 hours, cells 348 
were fixed and permeabilized, then labelled with anti-LAMP1 antibody. Phagocytosis was 349 
analysed in confocal microscopy. The z-stack (white arrow) demonstrated that tumour cells are 350 
located inside B6.WT and B6.TNF-/- macrophages after 4 hours and 24 hours incubation (Green, 351 
DFTD cells; Blue, macrophages; Red, LAMP1).   352 
 353 
Figure 2. IFNγ/LPS treated B6.TNF-/- BMDMs exhibited enhanced phagocytic efficiency 354 
of DFTD cells compared to B6.WT BMDMs. B6.WT and B6.TNF-/- BMDMs were treated 355 
with IFNγ/LPS, IFNγ alone, LPS alone, or IL-4 alone. BMDMs were labelled with CTV and 356 
DFTD cells were labelled with CFSE. After labelling, BMDMs were co-incubated with DFTD 357 
cells for 4 hours. The percentage of phagocytosed DFTD cells in the incubation of 37 °C (A, 358 
B) and 4 °C (C, D) was investigated by flow cytometry. The ratio of BMDMs: DFTD cells 359 
indicates effector: target (E:T). Data were from a total of 3-7 mice within two or three 360 
independent experiments (biological replicates), Δ p < 0.05 versus WT control, # p < 0.05 361 
versus B6.TNF-/- control, * p < 0.05 versus WT versus B6.TNF-/-, NS not significant. 362 
 363 
Figure 3: IFNγ/LPS, LPS activated B6.TNF-/- BMDMs are more effective at removing 364 
DFTD cells than B6.WT BMDMs after 24 hours incubation. BMDMs from B6.WT and 365 
B6.TNF-/- mice were treated with IFNγ/LPS, IFNγ alone, LPS alone, or IL-4 alone. BMDMs 366 
were labelled with CTV and DFTD cells were labelled with CFSE. After labelling, BMDMs 367 
were incubated with DFTD cells for 24 hours, and the absolute number of viable DFTD cells 368 
was calculated using flow cytometry with cell count beads. The ratio of BMDMs: DFTD cells 369 
indicates effector: target (E:T). Data were from a total of 3-7 mice within two or three 370 
independent experiments (biological replicates), * p < 0.05. 371 
 372 
Figure 4. Reduced NO production from IFNγ/LPS, LPS activated B6.TNF-/- macrophages 373 
phagocytosis of DFTD cells. B6.WT and B6.TNF-/- macrophages were stimulated with 374 
IFNγ/LPS, IFNγ or LPS overnight. Macrophages were co-incubated with DFTD cells at 10:1(A) 375 
and 5:1 (B) ratios, the concentration of NO in the cell culture supernatant was analysed in 376 
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Griess assay. The ratio of BMDMs: DFTD cells indicates effector: target (E:T). Data were from 377 
3 mice (biological replicates), ΔΔ p < 0.01 versus WT control, ## p < 0.01 versus B6.TNF-/- 378 
control, * p <0.05 versus WT versus B6.TNF-/-.  379 
 380 
Figure 5. NO is unrelated to the TNF involved macrophage phagocytosis of DFTD cells. 381 
B6.WT and B6.TNF-/- BMDMs were treated with IFNγ/LPS or IFNγ/LPS with L-NIL 382 
overnight. After incubation with BMDMs and DFTD cells for 24 hours, the numbers of DFTD 383 
cells at E:T 10:1 (A), 5:1 (B) ratios were analysed by flow cytometry and cell counting beads. 384 
The ratio of BMDMs: DFTD cells indicates effector: target (E:T). The numbers of DFTD cells 385 
were calculated as methods described. Data were from a total of  3-5 mice within two or three 386 
independent experiments (biological replicates), * p < 0.05, NS not significant. 387 
  388 
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